Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Cash from Investing Activities (2016 - 2026)

Kewaunee Scientific has reported Cash from Investing Activities over the past 17 years, most recently at -$668000.0 for Q1 2026.

  • Quarterly results put Cash from Investing Activities at -$668000.0 for Q1 2026, up 97.73% from a year ago — trailing twelve months through Jan 2026 was -$3.5 million (up 88.76% YoY), and the annual figure for FY2025 was -$30.9 million, down 606.63%.
  • Cash from Investing Activities for Q1 2026 was -$668000.0 at Kewaunee Scientific, up from -$1.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for KEQU hit a ceiling of -$278000.0 in Q3 2024 and a floor of -$29.4 million in Q1 2025.
  • Median Cash from Investing Activities over the past 5 years was -$683000.0 (2024), compared with a mean of -$2.6 million.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 6094.53% in 2025 and later surged 97.73% in 2026.
  • Kewaunee Scientific's Cash from Investing Activities stood at -$529000.0 in 2022, then plummeted by 139.13% to -$1.3 million in 2023, then soared by 46.01% to -$683000.0 in 2024, then tumbled by 129.87% to -$1.6 million in 2025, then skyrocketed by 57.45% to -$668000.0 in 2026.
  • The last three reported values for Cash from Investing Activities were -$668000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$771000.0 (Q3 2025) per Business Quant data.